Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Epidemiol Infect ; 148: e17, 2020 02 04.
Artigo em Inglês | MEDLINE | ID: mdl-32014073

RESUMO

In Hungary, between February 2017 and July 2019, 70 confirmed measles cases were reported, raising questions about the adequacy of population-level immunity. Although the assumed vaccination coverage is ≥99%, in a recent study, we detected potential gaps in the anti-measles humoral immunity. In Hungary, according to a decree by the Ministry of Public Welfare, beginning from 2021, the healthcare provider should conduct a serosurvey of anti-measles protection levels of healthcare professionals. To facilitate the compliance with this requirement, we developed a quick 'three-in-one' or 'triple' MMR (measles, mumps and rubella) indirect ELISA (IgG); an assay format that is currently not available commercially. High throughput applicability of the 'three-in-one' ELISA was verified using 1736 sera from routine laboratory residual samples, using an automated platform (Siemens BEP 2000 Advance). Assay verification was performed by comparing the full antigen repertoire-based 'target' assay with in-house 'control' assays using recombinant viral antigen coatings, and by validated commercially available kits. Indirect immunofluorescence was used as an independent reference method. Data were analysed using OriginLab, IBM SPSS, RStudio and MedCalc. In case of measles, we combined our current results with previously published data (Ntotal measles = 3523). Evaluation of anti-mumps and anti-rubella humoral antibody levels was based on the measurement of 1736 samples. The lowest anti-measles seropositivity (79.3%) was detected in sera of individuals vaccinated between 1978 and 1987. Considering the antigen-specific seropositivity ratios of all samples measured, anti-measles, -mumps and -rubella IgG antibody titres were adequate in 89.84%, 91.82% and 92.28%, respectively. Based on the virus-specific herd immunity threshold (HIT) values (HITMeasles = 92-95%, HITMumps = 75-86%, HITRubella = 83-86), it can be stated that regarding anti-measles immunity, certain age clusters of the population may have inadequate levels of humoral immunity. Despite the potential gaps in herd immunity, the use of MMR vaccine remains an effective and low-cost approach for the prevention of measles, mumps and rubella infections.


Assuntos
Anticorpos Antivirais/sangue , Análise Custo-Benefício , Ensaio de Imunoadsorção Enzimática/economia , Ensaio de Imunoadsorção Enzimática/métodos , Imunidade Humoral , Vacina contra Sarampo-Caxumba-Rubéola/imunologia , Adolescente , Automação Laboratorial/economia , Automação Laboratorial/métodos , Criança , Pré-Escolar , Feminino , Humanos , Hungria , Imunoglobulina G/sangue , Lactente , Recém-Nascido , Masculino , Vacina contra Sarampo-Caxumba-Rubéola/administração & dosagem , Resultado do Tratamento , Adulto Jovem
2.
Pathol Oncol Res ; 7(3): 178-84, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11692143

RESUMO

Hepatitis B virus (HBV) is the most meaningful risk factor in chronic hepatitis, cirrhosis and primary hepatocellular carcinoma (PHC). The hepatitis B virus X protein (HBxAg) is a multifunctional protein with many important functions in hepatocellular carcinogenesis. A monoclonal anti-HBxAg antibody was developed in our laboratory and characterized by different methods. Using this antibody HBxAg was detected in formaldehyde fixed paraffin embedded tissue sections of 72 liver biopsies from patients with acute hepatitis, chronic hepatitis, cirrhosis and primary hepatocellular carcinoma. The co-expression of hepatitis B surface antigen (HBsAg), hepatitis B core antigen (HBcAg) and HBxAg was compared. The histological and cytological localization of the detected HBxAg showed a characteristic distribution in different stages of HBV infection. Strong and diffuse nuclear reaction was detected in PHC cases in contrast to the focal, cytoplasmic and nuclear labeling in the acute and chronic B hepatitis cases. Our antibody seems to be a suitable prognostic marker for routine pathohistological diagnosis and for comparative pathological and epidemiological research on the development of PHC.


Assuntos
Anticorpos Monoclonais , Carcinoma Hepatocelular/diagnóstico , Antígenos da Hepatite B/imunologia , Hepatite B Crônica/diagnóstico , Neoplasias Hepáticas/diagnóstico , Transativadores/imunologia , Animais , Biópsia , Carcinoma Hepatocelular/imunologia , Ensaio de Imunoadsorção Enzimática , Feminino , Antígenos do Núcleo do Vírus da Hepatite B/imunologia , Antígenos de Superfície da Hepatite B/imunologia , Hepatite B Crônica/imunologia , Humanos , Immunoblotting , Técnicas Imunoenzimáticas , Cirrose Hepática/diagnóstico , Cirrose Hepática/imunologia , Neoplasias Hepáticas/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Prognóstico , Estudos Retrospectivos , Baço/imunologia , Proteínas Virais Reguladoras e Acessórias
3.
Am J Physiol ; 264(2 Pt 1): C411-8, 1993 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8447371

RESUMO

The recovery potential of skeletal muscle was explored by examining cat muscle between 10 and 33 mo after complete transection and immediate surgical reunion of its own nerve. Biochemical analysis of single muscle fibers showed that the activities of key enzymes in energy metabolism (malate and lactate dehydrogenase and adenylokinase) were similar to normal for their respective fiber types, suggesting that incomplete recovery of the ability to sustain submaximal contraction in reinnervated muscles (T.C. Cope, C.B. Webb, and B.R. Botterman. J. Neurophysiol. 65: 648-656, 1991) is explained in some other way. Two independent statistical procedures for assessing the randomness of adjacencies of histochemically identified fiber types showed type grouping in some areas, but there were also many regions with randomly distributed fiber types. These findings demonstrate the potential for substantial recovery of both energy metabolism and dispersion of fiber types after self-reinnervation.


Assuntos
Músculos/inervação , Regeneração Nervosa , Animais , Gatos , Metabolismo Energético , Histocitoquímica , Método de Monte Carlo , Músculos/anatomia & histologia , Músculos/enzimologia
4.
Prostaglandins ; 38(5): 581-97, 1989 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-2602563

RESUMO

Gastroprotection associated with the intragastric administration of prostaglandin (PG) precursor fatty acids such as linoleic (LA), gamma-linolenic (GLA), and arachidonic acid (AA) has been reported to be mediated via their conversion to PGs. This report examines the relationship between gastroprotection and the extent/rate of PG-release in rats intragastrically administered PG biosynthetic precursors: LA, AA, dihomo-gamma-linolenic acid (DHGL) or oleic acid (OA, a nonprecursor fatty acid). At various times following intragastric administration of a fatty acid, gastric fluid was collected, extracted, chromatographed, and assayed for PGE1 or PGE2 by specific radioimmunoassay. AA and DHGL dose dependently elevated gastric PGE2 and PGE1 levels, respectively. Maximal PGE elevation, 200-400 ng/stomach, was over 400-fold above basal values, and observed within 5-10 minutes of administration. Conversely, OA and LA elicited only a minor (2-10 fold) stimulation of PGE release. In contrast to effects on PG release, all four fatty acids protected the gastric mucosa against macroscopic damage induced by ethanol. The apparent rank order of potency was AA greater than DHGL = LA greater than OA (the difference in potency between DHGL or LA and OA was not significant). Since LA and OA (a nonprecursor) only marginally elevated lumenal PGs relative to DHGL or AA, yet were equally efficacious in the gastroprotection assay, it is likely that other fatty acid-related mechanisms play an important role in protecting the stomach against ethanol-induced injury.


Assuntos
Ácidos Graxos/farmacologia , Mucosa Gástrica/metabolismo , Prostaglandinas/metabolismo , Animais , Antiulcerosos , Ácidos Araquidônicos/metabolismo , Dinoprostona/metabolismo , Ácidos Graxos/isolamento & purificação , Mucosa Gástrica/efeitos dos fármacos , Intubação Gastrointestinal , Masculino , Prostaglandinas/biossíntese , Prostaglandinas/isolamento & purificação , Ratos , Ratos Endogâmicos , Estômago/efeitos dos fármacos , Úlcera Gástrica/induzido quimicamente , Úlcera Gástrica/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA